Publish in this journal
Journal Information
Vol. 62. Issue 12.
Pages 1450-1463 (December 2009)
Vol. 62. Issue 12.
Pages 1450-1463 (December 2009)
Full text access
Spanish Pacemaker Registry. 6th Official Report of the Spanish Society of Cardiology Working Group on Cardiac Pacing (2008)
Registro Español de Marcapasos. VI Informe Oficial de la Sección de Estimulación Cardiaca de la Sociedad Española de Cardiología (2008)
Visits
...
Raúl Coma Samartína, José Martínez Ferrerb, María José Sancho-Tello de Carranzac, Francisco Ruiz Mateasd, Juan Leal del Ojo Gonzáleze
a Sección de Estimulación Cardiaca, Sociedad Española de Cardiología, Madrid, Spain. Unidad de Estimulación Cardiaca. Unidad Coronaria, Hospital 12 de Octubre, Madrid, Spain
b Sección de Estimulación Cardiaca, Sociedad Española de Cardiología, Madrid, Spain. Unidad de Arritmias, Servicio de Cardiología, Hospital Txagurritxu, Vitoria, Álava, Spain
c Sección de Estimulación Cardiaca, Sociedad Española de Cardiología, Madrid, Spain. Unidad de Arritmias, Servicio de Cardiología, Hospital Universitario La Fe, Valencia, Spain
d Sección de Estimulación Cardiaca, Sociedad Española de Cardiología, Madrid, Spain. Unidad de Estimulación Cardiaca, Área de Cardiología, Hospital Costa del Sol, Marbella, Málaga, Spain
e Unidad de Electrofisiología y Arritmias, Servicio de Cardiología, Hospital Nuestra Señora de Valme, Sevilla, Spain
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (2)
TABLE 1. Hospitals That Have Submitted Data in 2008, by Autonomous Region
TABLE 1. Hospitals That Have Submitted Data in 2008, by Autonomous Region (continued)
Show moreShow less
Figures (16)
Show moreShow less
Introduction and objectives. This article describes the findings of an analysis of data on pacemaker implantations and replacements reported to the Spanish Pacemaker Registry during 2008. Methods. The data came primarily from information recorded on European Pacemaker Patient Identification Cards. Results. Data were received from 116 hospital units, which submitted a total of 11,855 identification cards representing 36.3% of all pacemakers implanted. There was a marked increase in the number of pacemaker units used, which rose to a rate of 708.3 per million inhabitants. The frequency of pacemaker implantation increased and the mean age of male patients decreased. The largest number of implantations were carried out in patients in their 70s, who comprised 39.1% of the total. The most frequent electrocardiographic indication was atrioventricular block. With regard to pacing leads, active fixation leads were used in the atrium in 59.3% of cases and in the ventricle in 37.9% of cases. There was an improvement in the choice of pacing mode, with age being a determining factor. For example, in sick sinus syndrome, the VVI/R mode was used in a 29% of patients aged over 80 years compared with 14% of those aged under 80 years. Conclusions. Age was found to be one factor influencing the selection of the most appropriate pacing mode. Active fixation leads were used more often, reaching 44.5% of leads implanted. Atrioventricular pacing was used in a greater percentage of cases than in any other time period covered by the pacemaker registry.
Keywords:
Registry
Pacemakers
Pacemaker leads
Biventricular pacing
Introducción y objetivos. En este artículo se describe el resultado del análisis de los implantes y recambios de marcapasos remitidos en 2008 al Registro Español de Marcapasos. Métodos. La recogida de datos se basa en la información de la Tarjeta Europea del Paciente Portador de Marcapasos. Resultados. Se recibió información de 116 centros hospitalarios, con un total de 11.855 tarjetas que suponen el 36,3% de los marcapasos implantados. Se objetiva un notable aumento del número de unidades consumidas, alcanzando 708,3 por millón de habitantes. Existe una mayor incidencia de implantes de marcapasos y a una media de edad más baja en varones, correspondiendo a la década de los setenta el mayor número de implantes, con el 39,1% del total. Los bloqueos auriculoventriculares aparecen como la más frecuente de las indicaciones electrocardiográficas. En los cables utilizados, el empleo del sistema de fijación activa supone el 59,3% de los auriculares y el 37% de los ventriculares. Se observa una mejor selección del modo de estimulación, siendo la edad un factor determinante, como por ejemplo en la enfermedad del nódulo sinusal, en la que se utiliza el modo VVI/R en el 29% de pacientes mayores de 80 años frente al 14% en los de edad inferior. Conclusiones. La edad es un factor que se muestra influyente en la adecuación del modo de estimulación. Aumenta la selección del sistema de fijación activa, alcanzando el 44,5% de los cables utilizados. La estimulación auriculoventricular registra el más alto porcentaje de utilización de todos los años analizados.
Palabras clave:
Registro
Marcapasos
Cables marcapasos
Estimulación biventricular
Full Text

INTRODUCTION

Publication of an annual report is one of the objectives of the Spanish Registry of Pacemakers (BNDM). This report presents the 2008 data on cardiac pacing with pacemakers in Spain, describes the most salient characteristics and the changes in recent years1-7, discusses how closely the pacing modes adhere to current clinical guidelines8,9, and facilitates hospital comparisons of their activity with the situation of pacing in Spain.

We maintained the same structure as previous reports published in the Revista Española de Cardiología. The BNDM has data available since 1994, but in some specific aspects, the period is shorter for technical reasons due to changes in the database software and the way in which the data were processed. Detailed information presented in multiple plots of the data referred to in previous years can be freely accessed at the web site of the Working Group on Cardiac Pacing (www. estimulacioncardiaca.org or www.marcapasossec. org).

An annual summary is also provided, providing general data on different aspects of the activity for the European Pacemaker registry.10 This registry has comparative data between countries and data on changes in countries that have been participating since 1994.11

METHODS

Report of the Spanish National Institute of Statistics

The national and regional population data for the various calculations for each year were taken from the most recent report published and updated by the Spanish National Institute of Statistics (INE) (www.ine.es).

European Pacemaker Patient Identification Card Information

The data and information collected are taken from the various sections of the European Pacemaker Patient Identification Card (EPPIcard),1 which should be filled out by the physician who implants the pacemaker and who should retain a copy to send to the BNDM. The EPPIcard is sent from the implicated hospitals or companies, in accordance with the current legislation on these implantable devices.2

The information on the EPPIcard can be sent in electronic format, just like the databases of the centers (in compliance with the security guidelines and measures demanded by the Law for Data Protection), with the choice left to the preference of those in charge of the registry in each center. With a view to facilitating this form of data transmission, and to ease the tedious process of data entry, the Working Group on Cardiac Pacing has its own database format,7 which is freely available. The aim is to harmonize and facilitate data collection and processing, although so far it has not had a significant impact on the performance of the registry.

The information sent to the registry is incorporated and cleaned by staff with extensive experience in the field of cardiac pacing. For processing and final analysis of data from the different fields of EPPIcard, dedicated software has been developed and is used in collaboration with the Information Technology Department of the Spanish Society for Cardiology.

Information From Different Companies

Although not all EPPIcards are sent in, the total number of pacemakers implanted in 1 year and their distribution according to autonomous region are obtained through the now commonplace cooperation of all companies that implant and distribute devices in Spain. These companies usually also provide this information to Eucomed (European Confederation of Medicals Suppliers Associations).

Sample Analyzed

In 2008, the BNDM received data on activity from 116 hospitals, which are included in the attached list, grouped by autonomous region (Table).

A total of 11 885 cards were processed, corresponding to implantations or replacement of pacemaker generators, while 373 from 1 center were discarded or not analyzed because they were not relevant to the registry. Despite the increase in the total number of cards, these still only account for 36.3% of the total number of generators, the same as the previous year.

Although it would obviously be preferable that this figure were 100%, the available sample is sufficient to provie us with knowledge of many different aspects of cardiac pacing in Spain.

RESULTS

Number of Pacemakers Implanted per Million Inhabitants

In 2008 a total of 32 154 conventional pacemaker generators and 542 cardiac pacing devices for cardiac resynchronization therapy without defibrillation (CRT-P) was implanted.

In 2008, the population census, according to information available from the INE, was 46.15 million inhabitants, with a population increase of practically 1 million persons per year.

In addition to the expected increase in the number of generators in line with the increase in the population, there was also an increase in the number of generators used per million inhabitants to 708.3 (Figure 1). As in previous years, there was an uneven distribution of the number of units per million inhabitants in the autonomous regions (Figure 2), calculated according to the population distribution published in the most recent update of the INE for that year. In the 2 previous years,7 a similar distribution was found, with a significantly higher number in the northern regions of Spain such as Galicia, Castile-León, and Asturias, with more than 900 pacemaker generators per million inhabitants in 2008. These regions have an older population, as reflected in the higher average age of the patients for whom data were submitted to the BNDM and in the higher percentage of the population who were over 75 years of age.7 This provides a likely explanation for the differences observed.

Figure 1. Total number of pacemaker generators and first implants consumed per million inhabitants, changes between 1994 and 2008.

Figure 2. Pacemakers implanted per million inhabitants, national average, and distribution by autonomous community, 2006 to 2008.

Cardiac Resynchronization Devices

The group of biventricular pacing devices used for cardiac resynchronization therapy has increased progressively to 38.7 units per million inhabitants, including low-energy devices (CRT-P) with 11.7 units per million inhabitants. After a leveling-off in the number of implanted CRT-P units in 2006 and 2007,7 an increase was seen in 2008 (Figure 3), but this represented a small percentage increase in the total number of generators to 1.6% (from 1.5% in 2007). This increase was much lower than that of the units with defibrillation capability. These units were those that contribute most to the annual total 1244 in 2008 (848 in 2006).

Figure 3. Cardiac resynchronization devices implanted in the past 4 years. CRD-D indicates dual-chamber generator with defibrillation capability; CRD-P, dual-chamber device with pacing only.

From the information submitted to the registry, biventricular CRT-P units represent 1.5% of first implants and 1.6% of generator replacements (for mode optimization or because the battery ran out).

Age and Sex of the Population

Age

The mean age of the patients who were implanted with a pacemaker system in 2008 was 76.3 years, while those who underwent replacement were slightly older, at 76.6 years. A small but progressive annual increase in the mean age can still be appreciated. This possibly reflects a shift in the population pyramid towards older age.

In 2008, a constant difference was maintained, as in previous years, in the mean age with respect to sex; this was somewhat lower in men (75.8 years) than in women (77 years).

The greatest number of implants was performed in patients in their 70s, with 39.1%, followed by those in their 80s, with 36.2%, whereas the greatest number of replacements was done in patients in their 80s (39.9%) followed by those in their 70s (33.3%). Limited activity was undertaken in patients aged 100 years or more (0.1% of all procedures; replacements in 0.24% and first implants in 0.08%).

Sex

More implants and generator replacements were used in men. Of all procedures, men accounted for 56.9%: 57.4% of first implants (Figure 4) and 55.3% of replacements (even though there were more women in the general population: 22.84 million men vs 23.31 million women). According to the proportion of implants in men and women in the registry, the number of devices implanted per million inhabitants was 815.8 in men and 603.2 in women. In addition, this greater incidence was evident for all decades of life.7

Figure 4. Pacemaker implantations by sex, 1994 to 2008.

Type of Procedure: First Implant and Pacemaker Replacement

Seventy-four percent of patients were implanted with a pacemaker for the first time. Generator replacement accounted for 26% of the procedures undertaken; a slight but continuous increase was observed in replacements with respect to the total number of procedures.

Generator replacements that required new leads during the procedure accounted for 1.6% of all reported activity.

The most frequent reason for generator replacement was the battery running out at the end of its useful life (88.5%). Other reasons reported less often were infection (2.1%), erosion of the generator bag (1.6%), elective procedure (3.6%), change because the battery ran out early (1.1%), change of system to improve hemodynamic results (0.5%), pacemaker syndrome (0.6%), and major or minor pacemaker defects (0.1%).

Pacemaker Leads

Almost all leads used were bipolar (99.6%), both in the atrium and the ventricle (99.9%) in both chambers, with this pacing system being the general choice. The small proportion of unipolar leads (0.4%) were used mainly for coronary sinus pacing (for cardiac resynchronization therapy or because of problems accessing the right ventricle as might happen after tricuspid valve replacement or with congenital abnormalities); a smaller percentage corresponded to epicardial leads implanted during heart surgery while on other occasions unipolar leads were chosen for their smaller caliber in special situations (multiple electrodes, venous stenosis, etc).

The distribution of the placement of the unipolar leads was as follows: 67.5% in the coronary sinus, 7.5% at an epicardial site, 20% at a ventricular site, and 5% at an atrial site.

Fixation or Anchoring System

Passive fixation of the leads (using flexible tines to stabilize the position in the trabeculae in the endocardium) has always been the method of choice compared to the so-called active system (with a helix, usually extendable, that penetrates the myocardium), but a trend towards greater acceptance and application of actively fixated leads could be appreciated. This may be due to several reasons: a) stabilization of the lead in adverse situations (for example, with severe tricuspid valve regurgitation); b) the possibility of pacing from the most desirable site (greater choice in different situations, such as the His or para-Hisian region, the outlet tract, or the right ventricular septum, atrial septum, etc); c) the thresholds of the current leads and the complications are comparable for both systems; and d) their isodiametric characteristic, which facilitated explantation.

In 2008, the atrial position for active fixation accounted for almost 60% while 38% of the leads were implanted at both locations (Figure 5).

Figure 5. Active lead fixation: percentage of total and of implants in the atrial and ventricular chambers. Changes from 2000 to 2008.

Explantation of Electrode Leads

The reasons indicated for explantation of the pacing leads were mostly infection or skin ulceration (52.9%), followed by displacement and breakage of the lead conductor, each accounting for 15%, and defective insulation and exit block (3%).

The intervention for implantation of a new lead alone (due to changes in its electrical characteristics) accounted for 0.2% of all procedures done, with replacement of a lead at the same time as change of generator in 1.6% (to improve the pacing mode or because of damage the cable or detection of unacceptably high thresholds during the replacement procedure).

Symptoms

The clinical manifestations responsible for the indication of implantation of the pacemakers were the following, in descending order of frequency: syncope in 44.5% of the cases, dizziness in 26.5%, dyspnea or signs of heart failure in 15.5%, and bradycardia in 8.9%. Other signs or symptoms reported less often were tachycardia (1.1%), chest pain (0.7%), brain dysfunction (0.5%), and risk of sudden death after return to bradyarrhythmia (0.2%). In 1.9%, the implantation was in asymptomatic patients or for a prophylactic indication.

Etiology

Among the etiologic causes for pacemaker implantation, the most commonly reported was unknown (43.4% of cases), followed by suspected fibrosis of the conduction system (39.4%), although both might fit within the same group, as the latter is an etiology determined by ruling out other possibilities. Ischemic etiology was the next most common cause (6.7%), with the subgroup of postinfarction patients corresponding to 0.4% of the total. The group of iatrogenic-therapeutic etiology accounted for 2.3% (those secondary to atrioventricular [AV] node ablation, whether intentional or not, corresponded to 1.2%, percentages very similar to previous years6,7).

The cardiomyopathy group accounted for 2.6% (0.4% for hypertrophy, the lowest percentage in recent years, possibly due to the decrease in pacing in patients with obstructive hypertrophic cardiomyopathy). The set of neuromediated, malignant vasovagal, and carotid sinus syndrome etiologies did not account for more than 2% of the overall procedures.

Electrocardiographic Disorders

The most common electrocardiographic disorders for which a new implant was indicated were third-degree AV block in 33.8% of the patients; conduction disorders as a group accounted for 54% followed by different types of sinus node dysfunction in 20.9% (sinoatrial exit block, sinoatrial node arrest, sinus bradycardiatachycardia, chronotropic incompetence, etc), or 37.4% if we also included patients with atrial fibrillation and bradycardia, code E6 on the EPPIcard.

With regard to sex, in 2008 it was apparent that, although there are fewer men than women in the population, more implantations were done in men for all conduction disorders. This was true for both AV conduction disorders and for intraventricular conduction disorders (IVCDs). However, in sick sinus syndrome (SSS) it is almost the same in both sexes, as in other years studied5-7 (number of implants in men/women was 1.41 for AV block, 2.18 for IVCD, and 1.08 for SSS), which is a reflection of the more frequent degeneration of the conduction system in men compared to women.

IVCDs accounted for 5.9% of all electrocardiographic disorders. No significant increase was apparent compared to recent years, despite the potential increase in number of indications for cardiac resynchronization, and this figure has remained around 5% to 6% in all years recorded.

Details of the subgroups mentioned and the changes in recent years can be seen in the attached figures (Figures 6 and 7).

Figure 6. Distribution of pre-implant electrocardiographic disorders in 2008. AT indicates atrial tachycardia; AFib/ AF+brad, atrial fibrillation or atrial flutter with slow ventricular response; AV block, atrioventricular block; D, degree; IVCD, intraventricular conduction disorder; SSS, sick sinus syndrome; VT, ventricular tachycardia.

Figure 7. Pre-implant electrocardiographic disorders, changes from 1994 to 2008. AFib/AF+brad indicates atrial fibrillation or atrial flutter with slow ventricular response; AV block, atrioventricular block; IVCD, intraventricular conduction disorder; SSS, sick sinus syndrome.

Pacing Methods

General

Of the generators used (first implant and replacements), single-chamber pacing accounted for 40.2% of the devices and dual-chamber ones with 1 or 2 leads for 59.7%. Isolated atrial pacing accounted for only a small percentage (1.3%); certain differences were observed between the first implants (1%) and the devices used for replacements (1.8%). This trend towards lower current usage is probably due to shifts towards more sophisticated dual-chamber devices, with new mode-switching AAIR/DDDR algorithms or AV intervals that facilitate intrinsic AV conduction, with a more "physiological" pacing behavior than the old dual-chamber models.

The use of devices for single-chamber ventricular pacing (VVIR) was 38.9%, with a slight variation between first implant (39.4%) and replacement devices (37.7%). Thus, there remains a group of patients who are in sinus rhythm and who are paced in VVIR mode. In the electrocardiographic disorders, the percentage of patients with permanent atrial tachyarrhythmia is 20.4%. These are the only patients who would clearly be candidates for this type of pacing, which is presented in detail in the following sections.

In sequential pacing, in single-lead VDD mode (although still accounting for 15.3% of all units employed), there was a marked difference between first implant (13.6%) and replacements (20.1%), indicating a trend towards less usage of this mode.

DDD stimulation was the most widely used, both overall and when broken down by first-time or replacement implantation, accounting for 44.4% of all generators used in the year (45.8% for first-time implants and 40% for replacements).

If we compare the modes of usage with previous years, there was a progressive increase in DDD units after a plateau reached between 2004 and 2007 and a slow decline in the number of VDD units,7 which, nevertheless, were implanted 4932 times in 2008 (Figure 8).

Figure 8.General change in pacing modes from 1994 to 2008.

Pacing was associated with one or more biosensors for frequency control in 89.5% of the cases.

AV Block Pacing

To study the quality of pacing in patients with AV block, the appropriateness of pacing and the trend towards pacing modes more recommended in the clinical guidelines,8,9 the analysis excluded the subgroup with code 8 on the EPPIcard, that is, patients with atrial tachyarrhythmia with AV block.

Atrial synchronized ventricular pacing was done in 75.9% of the cases, with 48.9% in DDDR mode and 27.1% in VDDR mode. Choice of pacing modes in 2008 was similar regardless of whether the analysis was by first- or second-degree AV block or third-degree AV block. The VDDR group accounted for 27% in both cases (Figure 9).

Figure 9. Pacing methods in atrioventricular blocks (AVB) grouped by first- and second-degree and third-degree blocks (2008).

Of note in the data for annual changes was the significant increase of 8% in the DDD group at the expense of lower usage of the other 2 modes, VDD and VVI. On examination of the trends, a slow decrease in the VDDR pacing mode can be seen; conduction disorders were the main indication (Figure 10).

Figure 10. Pacing methods used in atrioventricular block, from 1994 to 2008, excluding the patients in permanent atrial fibrillation.

When we analyze the distribution of pacing modes in the 2 age groups usually defined (≤80 years and >80 years), there was a notable difference in the use of modes that maintain AV synchrony, with this mode preferred in 87% of those under 80 years of age compared to 60% in those older than 80. VDDR mode was the one with least influence of age (Figure 11) in these groups and the one with the smallest changes over the years analyzed.7

Figure 11. Pacing methods used in atrioventricular block, by age groups of 80 years old or younger and over 80, excluding the patients in permanent atrial fibrillation (2008).

There was still a high percentage of VVIR pacing in patients with AV block in sinus rhythm, but there was a notable decrease in this mode of pacing compared to previous years, with the subsequent improvement in the choice of pacing mode. For the different types of AV block, VVIR mode accounted

for 24%. When choosing the pacing mode, age appeared as the determining factor (Figure 12). However, the degree of block had little influence on this choice, as it was only slightly less than in patients with less severe AV conduction disorders (first- and second-degree AV block, 22.5% vs third-degree AV block, 24.8%) (Figure 9).

Figure 12Change in VVIR pacing mode in atrioventricular block, according to age groups (2001-2008).

Pacing in Patients With Sick Sinus Syndrome

As in the previous group, patients with AFib/AF and bradycardia (code E6 EPPIcard) were excluded and analyzed separately from the group of patients who remained in sinus rhythm to prevent mode switching from interfering in the results.

In patients with SSS, pacing was done mainly in DDDR mode (74.2%) and AAIR mode was only used in 4.9% (overall, in 79.1%). These pacing modes, with atrial sensing and pacing capability, are the ones recommended for SSS in the clinical guidelines.8,9 In 2008, greater usage of DDDR mode was achieved, probably due to the use of generators with new AAIR/DDDR mode-switching algorithms, which are particularly indicated in this group of patients (Figure 13).

Figure 13. Pacing methods used in sick sinus syndrome, from 1994 to 2008 years, excluding the patients in permanent atrial fibrillation.

This year, it is of note that the smallest percentage of VVIR pacing was reported somewhat less than 20%. The VDDR mode, which is not very appropriate in this type of patient unless clearly justified, was still present in a low percentage of patients (1.2%). This can be explained by technical problems with implantation (Figure 13).

On analysis of influence of age on choice of mode by comparing 2 age groups (≤80 years and >80 years), a significant difference was seen in the use of DDDR mode: 79.9% in those aged under 80 years and 63% in those over 80 (for VVIR pacing, the percentages were 14.2% and 29.8%, respectively). AAIR mode

(although with similar and low percentages in both subgroups) was more widely used in the older age group (4.8% vs 5.5%) (Figure 14).

Figure 14. Pacing methods in sick sinus syndrome by age groups, 2008.

Although the percentage of patients who could benefit from atrial-based pacing remained constant in 2008, better adaptation of the modes was reported, even in older patients, thereby breaking the opposite trend of the last 2 years6,7 (Figure 15).

Figure 15.VVIR pacing method in sick sinus syndrome by age groups.

In the subgroup of patients with atrial tachyarrhythmia, atrial flutter or fibrillation, the most widely used pacing mode was VVIR (94.3%), as expected. DDD mode accounted for 4.9% and a VDD was used in a minimal number (0.7%) (probably in patients where there was an intention to revert to sinus rhythm).

Pacing in Intraventricular Conduction Disorders

In this group of electrocardiographic disorders, sequential or synchronous pacing remained at the same percentage as in 2007 (71.2%),7 and a notable shift towards VDDR and DDDR devices was seen. The most widely used pacing mode was DDDR, accounting for 57.3%, while VDDR accounted for 13.9% (Figure 16).

Figure 16. Pacing methods for intraventricular conduction disorders (2008) and change over the years for which data are available.

Single-chamber VVIR ventricular pacing has remained at a similar level over the past 4 years, with the current 28% being the same figure as in 2007 and 2005.

As in the previous sections, the VVIR pacing mode was more widely used in older patients; it was used in 45% of those over 80 years (the most widely used mode in this group), compared to 17% in patients under 80 years. The use of VDD mode was similar in both age groups (13.6% vs 14.3%, respectively), as in the previous years analyzed.

As with conventional generators, in IVCDs, the devices used for dual-chamber pacing CRT-P for treatment of heart failure in dilated cardiomyopathies showed notable differences: 11.8% in those aged 80 years or less and 1.9% in those over 80.

CONCLUSIONS

The number of pacemakers used per million inhabitants continued to increase and is now at 708.3 devices in 2008 (of which 524.1 corresponded to first implant), with marked regional differences due to the different ageing patterns of the population.

Replacement of pacemakers is an increasingly important part of the activity undertaken, accounting for 26% of the procedures in 2008.

In the adaptation of pacing mode to the different electrocardiographic disorders, age was a determining factor.

In 2008, sequential AV pacing was the most widespread indication of the conditions studied.

A gradual decrease in VDDR mode was seen, with 5000 units implanted per year.

The leads implanted were bipolar ones. The use of active fixation systems continues to increase, and are most often used for atrial sites.

The number of dual-chamber pacing devices, CRT-P, has increased, although this percentage change is not significant.

ACKNOWLEDGMENTS

We thank the registered nurses Pilar Gómez Pérez and Brígida Martínez Noriega, whose collaboration was essential for maintaining the quality of the registry. We also thank Gonzalo Justes Toha, information technology specialists at the SEC, for his valuable collaboration in setting up the computing application and analyzing the registry; all the health care professionals in the hospital centers who collaborated in sending in the European Pacemaker Patient Card, the source of the information analyzed; and the staff of the pacemaker manufacturers with implantation activity in Spain (Biotronik, Boston, Médico, Medtronic, Saint Jude, and Sorin Group) for their collaboration in sending in the cards and the general information on annual consumption of devices.

ABBREVIATIONS
AFib/AF: Atrial fibrillation/atrial flutter
AVB: Atrioventricular block
BNDM: Spanish Registry of Pacemakers
CRT-P: Cardiac resynchronization therapy (without ICD)
EPPIcard: European Pacemaker Patient Identification Cards
INE: Spanish National Institute of Statistics
IVCD: Intraventricular conduction disorder
SSS: Sick sinus syndrome


Correspondence: Dr. R. Coma Samartín. Arturo Soria, 184. 28043 Madrid. España.
E-mail: coma@vitanet.nu

Bibliography
[1]
Coma Samartín R..
Estado actual de la estimulación cardiaca permanente en España. Informe del Banco Nacional de Datos de Marcapasos..
Rev Esp Cardiol, 50 (1997), pp. 760-5
[2]
Coma Samartín R..
Banco Nacional de datos de Marcapasos. Informe año 2002..
Cuadernos T??cnicos de Estimulaci??n Cardiaca, 10 (2004), pp. 37-42
[3]
Coma Samartín R..
Registro Español de Marcapasos. II Informe oficial de la Sección de Estimulación Cardiaca, de la Sociedad Española de Cardiología (1994-2003)..
Rev Esp Cardiol, 57 (2004), pp. 1205-12
[4]
Coma Samartín R, Martínez Noriega B, Gómez Pérez P..
Informe del Banco Nacional de Datos de Marcapasos. Año 2004..
Cuadernos T??cnicos de Estimulaci??n Cardiaca, 14 (2006), pp. 25-32
[5]
Coma Samartín R, García Calabozo R, Martínez Ferrer J, Sancho Tello MJ, Ruiz Mateas F, Registro Español de Marcapasos..
III Informe Oficial de la Sección de Estimulación Cardiaca de la Sociedad Española de Cardiología (2005)..
Rev Esp Cardiol, 59 (2006), pp. 1303-13
[6]
Coma Samartín R, Martínez Ferrer J, Sancho-Tello de Carranza MJ, Ruiz Mateas F, Leal del Ojo-González J..
Registro Español de Marcapasos. IV Informe Oficial de la Sección de Estimulación Cardiaca de la Sociedad Española de Cardiología (2006)..
Rev Esp Cardiol, 60 (2007), pp. 1302-13
[7]
Coma Samartín R, Martínez Ferrer J, Sancho-Tello de Carranza MJ, Ruiz Mateas F, Leal del Ojo-González J..
Registro Español de Marcapasos. V Informe Oficial de la Sección de Estimulación Cardiaca de la Sociedad Española de Cardiología (2007)..
Rev Esp Cardiol, 61 (2008), pp. 1302-13
[8]
Vardas P, Auriccio A, Blanc JJ, Daubert JC, Drexler H, Ector H, et al..
Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with de European Heart Rhythm Association..
Europace, 9 (2007), pp. 95998
[9]
Epstein AR, DiMarco JP, Kenneth A, Ellembogen K, Mark Estes NA, Freedman RA, et al..
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities..
Circulation, 117 (2008), pp. e350-408
[10]
Ector H, Rickards AF, Kappenberger L, Vardas P, Oto A, Santini M, et al..
The Registry of European Working Group on Cardiac Pacing (EWGCP)..
Europace, 2 (2000), pp. 251-5
[11]
Vardas P, Ovsyscher E..
Geographic Differences of Pacemaker Implant Rates in Europe..
J Cardiovasc Electrophysiol, 13 (2002), pp. S23-6
Idiomas
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

View newsletter history
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?